Your browser doesn't support javascript.
loading
A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients.
Lee, Eudocia Q; Kaley, Thomas J; Duda, Dan G; Schiff, David; Lassman, Andrew B; Wong, Eric T; Mikkelsen, Tom; Purow, Benjamin W; Muzikansky, Alona; Ancukiewicz, Marek; Huse, Jason T; Ramkissoon, Shakti; Drappatz, Jan; Norden, Andrew D; Beroukhim, Rameen; Weiss, Stephanie E; Alexander, Brian M; McCluskey, Christine S; Gerard, Mary; Smith, Katrina H; Jain, Rakesh K; Batchelor, Tracy T; Ligon, Keith L; Wen, Patrick Y.
Afiliação
  • Lee EQ; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts. Harvard Medical School, Boston, Massachusetts.
  • Kaley TJ; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Duda DG; Harvard Medical School, Boston, Massachusetts. Massachusetts General Hospital, Boston, Massachusetts.
  • Schiff D; University of Virginia, Charlottesville, Virginia.
  • Lassman AB; New York-Presbyterian Hospital/Columbia University Medical Center, New York, New York.
  • Wong ET; Harvard Medical School, Boston, Massachusetts. Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Mikkelsen T; Henry Ford Hospital, Detroit, Michigan.
  • Purow BW; University of Virginia, Charlottesville, Virginia.
  • Muzikansky A; Harvard Medical School, Boston, Massachusetts. Massachusetts General Hospital, Boston, Massachusetts.
  • Ancukiewicz M; Massachusetts General Hospital, Boston, Massachusetts.
  • Huse JT; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Ramkissoon S; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts. Harvard Medical School, Boston, Massachusetts.
  • Drappatz J; University of Pittsburgh Medical Center, Cancer Centers, Pittsburgh, Pennsylvania.
  • Norden AD; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts. Harvard Medical School, Boston, Massachusetts.
  • Beroukhim R; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts. Harvard Medical School, Boston, Massachusetts.
  • Weiss SE; Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Alexander BM; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts. Harvard Medical School, Boston, Massachusetts.
  • McCluskey CS; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Gerard M; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Smith KH; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Jain RK; Harvard Medical School, Boston, Massachusetts. Massachusetts General Hospital, Boston, Massachusetts.
  • Batchelor TT; Harvard Medical School, Boston, Massachusetts. Massachusetts General Hospital, Boston, Massachusetts.
  • Ligon KL; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts. Harvard Medical School, Boston, Massachusetts.
  • Wen PY; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts. Harvard Medical School, Boston, Massachusetts. Patrick_Wen@dfci.harvard.edu.
Clin Cancer Res ; 21(16): 3610-8, 2015 Aug 15.
Article em En | MEDLINE | ID: mdl-25910950
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidinas / Quinazolinas / Glioblastoma / Dacarbazina Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidinas / Quinazolinas / Glioblastoma / Dacarbazina Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article